Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) ≠ 1931
  • (-) = Guchelaar, H.J.

Refine Results

Resource Type

Availability

Creation Date

Show more

Topic

Show more

Author

Show more

Language

Search results

  • RSS Feed
(97 - 120 of 375)

Pages

Population pharmacokinetics of treosulfan in paediatric patients undergoing hematopoietic stem cell transplantation
Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM Reply
Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease
Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact
Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands
Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen
Non-Cancer Drug Repurposing Candidates for Renal Cell Carcinoma
Transcriptome Signature Reversion as a Method to Reposition Drugs Against Cancer for Precision Oncology
Adverse drug reactions on sexual functioning: a systematic overview
Confirmation practice in pharmacogenetic testing; how good is good enough?
Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? reply
The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy
Validation of a clinical pharmacogenetic model to predict methotrexate nonresponse in rheumatoid arthritis patients
Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device
Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants
Food-effect study on uracil and dihydrouracil plasma levels as marker for dihydropyrimidine dehydrogenase activity in human volunteers
Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab
Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers
Genetic polymorphisms of 3-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
Pharmacogenomics, a novel section in the European Journal of Human Genetics

Pages